ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma

Yang, Yongyu; Xiao, Wang; Liu, Ruoqi; Gao, Lei; Chen, Junzhang; Kan, Heping*南方医科大学
Journal of Immunology Research2022-11-10DOI: 10.1155/2022/4983532
2被引6阅读
引用收藏
分享

摘要

Background. Lamin family members play crucial roles in promoting oncogenesis and cancer development. The values of lamin family in predicting prognosis and immunotherapy response remain largely unclarified. Our research is aimed at comprehensively estimating the clinical significance of lamin family in hepatocellular carcinoma and constructing a novel lamin family-based signature to predict prognosis and guide the precise immunotherapy. Methods. The expression features and prognostic value of LMNA, LMNB1, and LMNB2 were explored in the TCGA and GEO databases. The biological functions of LMNB1 and LMNB2 were validated by in vitro assays. A lamin family-based signature was built using the TCGA training set. The TCGA test set, entire TCGA set, and GSE14520 set were used to validate its predictive power. Univariate and multivariate analyses were performed to evaluate the independence of the lamin family-based signature from other clinicopathological characteristics. A nomogram was constructed using the lamin family-based signature and TNM stage. The associations of this signature with molecular pathways, clinical characteristics, immune cell infiltration, and immunotherapy response were analyzed. Results. Lamin family members were upregulated in HCC. Upregulation of LMNB1 and LMNB2 promoted HCC proliferation, migration, and invasion. The predictive signature was initially established based on LMNB1 and LMNB2 which could effectively identify differences in overall survival, immune cell infiltration, and clinicopathological characteristics of high- and low-risk patients. The nomogram showed high prognostic predictive accuracy. Importantly, the lamin family-based signature was correlated with immune suppression and expression of immune checkpoint molecules. Conclusions. The lamin family-based signature is a robust biomarker to predict overall survival and immunotherapy response in HCC. High-risk score patients have a poorer overall survival and might be more sensitive to immunotherapy. This signature may contribute to improving individualized prognosis prediction and precision immunotherapy for HCC patients.

学科与关键词

关键词
CO-INHIBITORY RECEPTORSTHERAPEUTIC TARGETCANCERB1EXPRESSIONBIOMARKERTIGITLMNB1TIM-3LAG-3
相关
加载中…
  • Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma
    Yang, Yongyu; Gao, Lei; Chen, Junzhang; Xiao, Wang; Liu, Ruoqi; Kan, Heping*Bioengineered, 2022, 13(4): 9211-9231.被引 5
  • Comprehensive Analysis of the Prognostic Values of the TRIM Family in Hepatocellular Carcinoma
    Dai, Weiyu; Wang, Jing; Wang, Zhi; Xiao, Yizhi; Li, Jiaying; Hong, Linjie; Pei, Miaomiao; Zhang, Jieming; Yang, Ping; Wu, Xiaosheng; Tang, Weimei; Jiang, Xiaoling; Jiang, Ping; Xiang, Li; Li, Aimin*; Lin, Jianjiao*; Liu, Side*; Wang, Jide*Frontiers in Oncology, 2021, 11: 767644.被引 15
  • Inflammatory Response-Related Long Non-Coding RNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
    Li, Xinyu; Zhang, Shuqiao; Zhang, Shijun; Kuang, Weihong; Tang, Chunzhi*Journal of Oncology, 2022, 2022: 9917244.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Immunology Research
发表日期
2022-11-10
卷期
第 2022 卷
页码
4983532
DOI
10.1155/2022/4983532
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province; [NSF-GP 2016A030313555]

作者

  • Y

    Yang, Yongyu (第一作者)

    southern med univ

  • X

    Xiao, Wang

    southern med univ

查看全部 6 位作者收起作者
  • L

    Liu, Ruoqi

    southern med univ

  • G

    Gao, Lei

    southern med univ

  • C

    Chen, Junzhang

    southern med univ

  • K

    Kan, Heping (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417